Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01604408 · ClinicalTrials.gov registry record · Phase 2
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 201
- Enrollment target
NCT01604408 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 201 participants.
The verdict
NCT01604408, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 201 participants
- Enrollment target
Study Summary
LY2495655 is an investigational drug being tested for muscle wasting.
Interventions
- DRUG Placebo
- BIOLOGICAL LY2495655
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01604408
The ClinicalTrials.gov registry entry for NCT01604408 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01604408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01604408 about?
NCT01604408 is a clinical study titled "A Study in Older Participants Who Have Fallen and Have Muscle Weakness". LY2495655 is an investigational drug being tested for muscle wasting.
What is the current status of trial NCT01604408?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 201 participants. The study started on 2012-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01604408?
The interventions under investigation include: Placebo (DRUG), LY2495655 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01604408?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.